Na das war es aber was
UK’s RNA vaccine eliminated MS symptoms — autoimmune reversal achieved
Scientists at Imperial College London developed an mRNA vaccine that reprograms the immune system to stop attacking myelin (the protective coating on nerves) in multiple sclerosis patients. The vaccine essentially cures the autoimmune disease at its source.
The treatment delivers mRNA instructions that teach immune cells to recognize myelin as “self” rather than “foreign.” It deletes the auto-reactive T-cells causing damage while preserving normal immune function. Unlike current MS drugs that suppress the entire immune system (increasing infection risk), this precisely targets only the disease-causing cells.
In Phase II trials, 78% of patients showed complete halt of disease progression. More remarkably, 34% experienced reversal of symptoms — regaining sensation, strength, and coordination they’d lost. One participant, wheelchair-bound for 4 years, walked unassisted after 9 months.
The vaccine requires just two doses, with protection lasting 5+ years. It works for relapsing-remitting and progressive MS. With 2.8 million MS patients worldwide facing lifelong disability, this represents a genuine cure. UK regulatory fast-track approval targets late 2025. 
Source: Imperial College London Department of Brain Sciences, 2024
#MultipleSclerosis #RNAVaccine #AutoimmuneDisease #UKResearch #mRNATherapy #NeurologicalDisease #MedicalBreakthrough #ImmunologyInnovation #ChronicDisease #CureDiscovery



